Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-12-04 | New | $14,791,454 | $14,791,454 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Denitsa Milanova | Director, Executive |
| Matthew Rabinowitz | Director |
| Nicholas P. Restifo | Executive |
| David Thompson | Executive |